Eradication of Helicobacter pylori is associated with the progression of dementia: A population-based study

Gastroenterology Research and Practice

Volumn 2013, Issue , 2013, Pages

  Chang, Yang Pei ^a   Chiu, Guei Fen ^b   Kuo, Fu Chen ^c,d   Lai, Chiou Lian ^a   Yang, Yuan Han ^a   Hu, Huang Ming ^a,e   Chang, Pi Yu ^a   Chen, Chiao Yun ^a,e   Wu, Deng Chyang ^a,f   Yu, Fang Jung ^a,e  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^f KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893758242     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2013/175729     Document Type: Article

References (32)

1. Eikelenboom P., Bate C., van Gool W. A., Hoozemans J. J. M., Rozemuller J. M., Veerhuis R., Williams A., Neuroinflammation in Alzheimer's disease and prion disease. Glia 2002 40 2 232 239 2-s2.0-0036850023 10.1002/glia.10146 (Pubitemid 35337380)
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G. M., Cooper N. R., Eikelenboom P., Emmerling M., Fiebich B. L., Finch C. E., Frautschy S., Griffin W. S. T., Hampel H., Hull M., Landreth G., Lue L.-F., Mrak R., MacKenzie I. R., McGeer P. L., O'Banion M. K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., van Muiswinkel F. L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T., Inflammation and Alzheimer's disease. Neurobiology of Aging 2000 21 3 383 421 2-s2.0-0034612175 10.1016/S0197-4580(00)00124-X (Pubitemid 30349107)
3. Farrer L. A., Cupples L. A., Haines J. L., Hyman B., Kukull W. A., Mayeux R., Myers R. H., Pericak-Vance M. A., Risch N., van Duijn C. M., Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. Journal of the American Medical Association 1997 278 16 1349 1356 2-s2.0-0030823158 (Pubitemid 27449696)
4. Seshadri S., Beiser A., Selhub J., Jacques P. F., Rosenberg I. H., D'Agostino R. B., Wilson P. W. F., Wolf P. A., Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. The New England Journal of Medicine 2002 346 7 476 483 2-s2.0-0037075257 10.1056/NEJMoa011613 (Pubitemid 34441738)
5. Wozniak M. A., Itzhaki R. F., Antiviral agents in Alzheimer's disease: hope for the future? Therapeutic Advances in Neurological Disorders 2010 3 3 141 152 2-s2.0-77953463815 10.1177/1756285610370069
6. Loeb M. B., Molloy D. W., Smieja M., Standish T., Goldsmith C. H., Mahony J., Smith S., Borrie M., Decoteau E., Davidson W., McDougall A., Gnarpe J., O'Donnell M., Chernesky M., A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer's disease. Journal of the American Geriatrics Society 2004 52 3 381 387 2-s2.0-12144290676 10.1111/j.1532-5415. 2004.52109.x (Pubitemid 38339518)
7. Miklossy J., Chronic inflammation and amyloidogenesis in Alzheimer's disease-role of spirochetes. Journal of Alzheimer's Disease 2008 13 4 381 391 2-s2.0-47849120645 (Pubitemid 352039022)
8. Figura N., Franceschi F., Santucci A., Bernardini G., Gasbarrini G., Gasbarrini A., Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2010 15 1 60 68 2-s2.0-78249236864 10.1111/j.1523-5378.2010.00778.x
9. Kountouras J., Boziki M., Gavalas E., Zavos C., Grigoriadis N., Deretzi G., Tzilves D., Katsinelos P., Tsolaki M., Chatzopoulos D., Venizelos I., Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease. Journal of Neurology 2009 256 5 758 767 2-s2.0-67349144455 10.1007/s00415-009-5011-z
10. Pac-Soo C., Lloyd D. G., Vizcaychipi M. P., Ma D., Statins: the role in the treatment and prevention of Alzheimer's neurodegeneration. Journal of Alzheimer's Disease 2011 27 1 1 10 2-s2.0-80155191187 10.3233/JAD-2011-110524
11. Kurata T., Miyazaki K., Kozuki M., Panin V.-L., Morimoto N., Ohta Y., Nagai M., Ikeda Y., Matsuura T., Abe K., Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice. Brain Research 2011 1371 161 170 2-s2.0-78651365099 10.1016/j.brainres. 2010.11.067
12. Infante-Duarte C., Waiczies S., Wuerfel J., Zipp F., New developments in understanding and treating neuroinflammation. Journal of Molecular Medicine 2008 86 9 975 985 2-s2.0-46849108620 10.1007/s00109-007-0292-0
13. Farooqui A. A., Ong W.-Y., Horrocks L. A., Chen P., Farooqui T., Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans. Brain Research Reviews 2007 56 2 443 471 2-s2.0-36448947190 10.1016/j.brainresrev.2007.09.004 (Pubitemid 350166530)
14. Roubaud-Baudron C., Krolak-Salmon P., Quadrio I., Mégraud F., Salles N., Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results. Neurobiology of Aging 2012 33 5 e11 e19 2-s2.0-84858338648 10.1016/j.neurobiolaging.2011.10.021
15. Wu C.-Y., Kuo K. N., Wu M.-S., Chen Y.-J., Wang C.-B., Lin J.-T., Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 2009 137 5 1641.e2 1648.e2 2-s2.0-70350102177 10.1053/j.gastro.2009.07.060
16. Wu I.-C., Wu D.-C., Hsu P.-I., Lu C.-Y., Yu F.-J., Wang T.-E., Chang W.-H., Chen J.-J., Kuo F.-C., Wu J.-Y., Wang W.-M., Bair M.-J., Rabeprazole- versus esomeprazole-based eradication regimens for H. pylori infection. Helicobacter 2007 12 6 633 637 2-s2.0-36248964131 10.1111/j.1523-5378.2007. 00553.x (Pubitemid 350132067)
17. Eshraghian A., The continuous story of Helicobacter pylori infection and insulin resistance: this time in Japan. Helicobacter 2010 15 2 160 2-s2.0-77749239901 10.1111/j.1523-5378.2009.00741.x
18. Gunji T., Matsuhashi N., Sato H., Fujibayashi K., Okumura M., Sasabe N., Urabe A., Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 2009 14 5 144 150 2-s2.0-70349157295 10.1111/j.1523-5378.2009.00705.x
19. Chung G. E., Heo N. J., Park M. J., Chung S. J., Kang H. Y., Kang S. J., Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria. World Journal of Gastroenterology 2013 19 1 97 102 10.3748/wjg.v19.i1.97
20. Pasceri V., Patti G., Cammarota G., Pristipino C., Richichi G., di Sciascio G., Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis. American Heart Journal 2006 151 6 1215 1222 2-s2.0-33744978738 10.1016/j.ahj.2005.06.041 (Pubitemid 43866599)
21. Elkind M. S. V., Cole J. W., Do common infections cause stroke? Seminars in Neurology 2006 26 1 88 99 2-s2.0-33244488507 (Pubitemid 43277366)
22. Corrado E., Rizzo M., Tantillo R., Muratori I., Bonura F., Vitale G., Novo S., Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke 2006 37 2 482 486 2-s2.0-33644855625 10.1161/01.STR.0000198813.56398.14 (Pubitemid 43732010)
23. Markus H. S., Mendall M. A., Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. Journal of Neurology Neurosurgery and Psychiatry 1998 64 1 104 107 2-s2.0-0031982165 (Pubitemid 28156546)
24. Schimke K., Chubb S. A. P., Davis W. A., Davis T. M. E., Helicobacter pylori cytotoxin-associated gene-A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes study. Atherosclerosis 2010 212 1 321 326 2-s2.0-79952111193
25. Cechetto D. F., Hachinski V., Whitehead S. N., Vascular risk factors and Alzheimer's disease. Expert Review of Neurotherapeutics 2008 8 5 743 750 2-s2.0-43249116399 10.1586/14737175.8.5.743 (Pubitemid 351656825)
26. Miao J., Xu F., Davis J., Otte-Höller I., Verbeek M. M., van Nostrand W. E., Cerebral microvascular amyloid β protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid β precursor protein. American Journal of Pathology 2005 167 2 505 515 2-s2.0-25144486849 (Pubitemid 43026105)
27. Miao J., Vitek M. P., Xu F., Previti M. L., Davis J., van Nostrand W. E., Reducing cerebral microvascular amyloid- β protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice. Journal of Neuroscience 2005 25 27 6271 6277 2-s2.0-21844476174 10.1523/JNEUROSCI.1306-05.2005 (Pubitemid 40962521)
28. Deane R., Zlokovic B. V., Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Current Alzheimer Research 2007 4 2 191 197 2-s2.0-34147183707 10.2174/156720507780362245 (Pubitemid 46562394)
29. Paul J., Strickland S., Melchor J. P., Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. Journal of Experimental Medicine 2007 204 8 1999 2008 2-s2.0-34547791784 10.1084/jem.20070304 (Pubitemid 47236333)
30. Verghese P. B., Castellano J. M., Holtzman D. M., Apolipoprotein E in Alzheimer's disease and other neurological disorders. The Lancet Neurology 2011 10 3 241 252 2-s2.0-79951713725 10.1016/S1474-4422(10)70325-2
31. Roses A. D., Apolipoprotein E and Alzheimer's disease: a rapidly expanding field with medical and epidemiological consequences. Annals of the New York Academy of Sciences 1996 802 50 57 2-s2.0-0030481305 10.1111/j.1749-6632. 1996.tb32598.x (Pubitemid 27055499)
32. Saunders A. M., Schmader K., Breitner J. C. S., Benson M. D., Brown W. T., Goldfarb L., Goldgaber D., Manwaring M. G., Szymanski M. H., McCown N., Dole K. C., Schmechel D. E., Strittmatter W. J., Pericak-Vance M. A., Roses A. D., Apolipoprotein E ε 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. The Lancet 1993 342 8873 710 711 2-s2.0-0027337858 10.1016/0140-6736(93)91709-U (Pubitemid 23279765)